Natera (NTRA) Share-based Compensation (2014 - 2026)
Natera's (NTRA) quarterly Share-based Compensation came in at $103.1 million in Q2 2026, up 985.46% on a YoY basis from $9.5 million in Q2 2025, and up 8.4% quarter-over-quarter from $95.1 million in Q1 2026.
Analysis
Natera (NTRA) Share-based Compensation (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported Share-based Compensation for 13 consecutive years, with $103.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Share-based Compensation rose 985.46% year-over-year to $103.1 million; the trailing twelve-month figure through Jun 2026 stood at $381.4 million (up 3915.82% YoY), and the FY2025 full-year result was $636.9 million, up 25.03% from the prior year.
- Share-based Compensation improved to $103.1 million in Q2 2026 per NTRA's latest filing, from $95.1 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $103.1 million in Q2 2026 and bottomed at $9.5 million in Q2 2025.
- Historically, Share-based Compensation has averaged $60.4 million across 5 years, with a median of $61.0 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Share-based Compensation sank 85.91% in 2025, then jumped 985.46% in 2026.
- Over 5 years, Share-based Compensation stood at $36.0 million in 2022, then surged by 37.36% to $49.4 million in 2023, then surged by 45.5% to $71.9 million in 2024, then rose by 28.72% to $92.6 million in 2025, then gained by 11.36% to $103.1 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $103.1 million, $95.1 million, and $92.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 103.10 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 6.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 26.80 Mn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 57.73 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 54.12 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 22.22 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 7.38 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 8.22 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 11.12 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 20.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 103.10 Mn |
| Mar 31, 2026 | 95.11 Mn |
| Dec 31, 2025 | 92.58 Mn |
| Sep 30, 2025 | 90.64 Mn |
| Jun 30, 2025 | 9.50 Mn |
| Mar 31, 2025 | 77.83 Mn |
| Dec 31, 2024 | 71.93 Mn |
| Sep 30, 2024 | 70.64 Mn |
| Jun 30, 2024 | 67.41 Mn |
| Mar 31, 2024 | 64.45 Mn |
| Dec 31, 2023 | 49.43 Mn |
| Sep 30, 2023 | 57.59 Mn |
| Jun 30, 2023 | 44.31 Mn |
| Mar 31, 2023 | 40.48 Mn |
| Dec 31, 2022 | 35.99 Mn |
| Sep 30, 2022 | 40.34 Mn |
| Jun 30, 2022 | 40.97 Mn |
| Mar 31, 2022 | 35.09 Mn |
| Dec 31, 2021 | 30.42 Mn |
| Sep 30, 2021 | 26.46 Mn |